Many advances have been made in the last decade in the diagnosis and treatment of prostate cancer. One stellar example is the MRI-guided fusion biopsy of the prostate. It represents a quantum leap forward in the identification of who would benefit from a prostate biopsy, as well as increasing the accuracy of the biopsy itself. These advantages allow for a better assessment of the presence, grade, and extent of prostate cancer.
While standard ultrasound-based prostate biopsy continues to be appropriate for many men, others may require a unique approach. This may include men in whom cancer is suspected despite a prior normal prostate biopsy, as well as men with larger prostate glands in which small cancers may not have been detected on standard biopsy.
At Georgia Urology, with assistance from our skilled Northside Radiology Associates, we utilize the KOELIS Trinity® biopsy system, which utilizes state-of-the-art real-time 3D MRI-ultrasound fusion technology. The suspicious lesions are detected on multiparametric prostate MRI, defined and outlined with millimetric precision. The MRI and live ultrasound images are fused, matching anatomical points and improving the accuracy of sampling the lesions of interest. These are outpatient biopsies, done under the comfort of brief anesthesia.
Literature consistently finds the superiority of this approach in detecting clinically significant prostate cancers. If you are being considered for a prostate biopsy and want our experts to review if you are a candidate for this technology, please contact Georgia Urology for a consultation.